Overview

The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

Status:
Completed
Trial end date:
2017-02-15
Target enrollment:
Participant gender:
Summary
This project focuses on development of new strategy for the prevention of exercise-associated hypoglycemia using mini-dose glucagon.
Phase:
Phase 2
Details
Lead Sponsor:
Jaeb Center for Health Research
Collaborator:
Xeris Pharmaceuticals
Treatments:
Glucagon
Glucagon-Like Peptide 1
Insulin
Insulin, Globin Zinc